Skip to main content

US ClosedU.S. Closed

PROK: ProKidney Corp. Stock Analysis | finqOS

Healthcare · Biotechnology

ProKidney Corp. is a biotechnology firm currently in the clinical trial phase, specializing in the development of innovative cell-based treatments.

52W Range

24thpctl

Volume

1.03×avg

Market Cap

615.34MUSD

P/E Ratio

-3.2TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

ProKidney Corp.

PROKNASDAQ Capital Market·USD·Closed

ProKidney Corp.

PROKNASDAQ·USD·Closed

$1.83

+0.55%

$1.83

+$0.01 (0.55%)

52W Range

24thpctl

Volume

1.03×avg

Mkt Cap

615.34MUSD

P/E

-3.2TTM

Div Yield

–ann